5th September 2006:

Aurora BioScience today received TGA approval to market Cyberonics' VNS System Therapy in Australia

Aurora BioScience Pty. Ltd. today received TGA approval to market Cyberonics'  Vagus Nerve Stimulation (VNS) Therapy System in Australia.  The Vagus Nerve Stimulation (VNS) Therapy System is used in the treatment of epilepsy.  

VNS Therapy delivers stimulation via a device implanted just under the skin in the left chest area. The pacemaker-like device sends mild, intermittent electrical impulses through a lead to the left vagus nerve, which then sends signals to the brain.¹ Each device is programmed for the individual patient, and the patient has the ability to initiate or abort stimulation with the use of a hand-held magnet.

¹Physician’s Manual, VNS Therapy Pulse Model 102 Generator. Houston, Texas: Cyberonics Inc.; 2003.

 

ABOUT VNS THERAPY AND CYBERONICS

Further information about Cyberonics, Inc. and the VNS Therapy System is available at www.cyberonics.com and www.VNSTherapy.com.

Click here to return to Main News Page.